Epizyme Aktie
WKN DE: A1T9L2 / ISIN: US29428V1044
02.09.2014 23:25:11
|
Epizyme CFO Jason Rhodes Resigns
(RTTNews) - Epizyme Inc (EPZM), a clinical stage biopharmaceutical company focusing on genetically defined cancers, said Tuesday its Chief Financial Officer Jason Rhodes would resign from the company, effective September 30. Rhodes will be joining a venture capital firm.
The company has a search underway to identify a new CFO, and Rhodes has agreed to assist Epizyme in an advisory capacity through the end of 2014 to ensure a smooth transition.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Epizyme Incmehr Nachrichten
Keine Nachrichten verfügbar. |